The role of cromakalim and a nitric oxide synthase blocker in cardiac arrhythmia in the intact baboon model

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 2, 2000, Pages 282-286

  Hay, L ^a   Schutte, P J ^a   Du Plooy, W J ^a   Kahler, C P ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

Baboon; Cardiac arrhythmia; Cromakalim; Hemodynamics; L NAME

Indexed keywords

CROMAKALIM; N(G) METHYLARGININE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARRHYTHMOGENESIS; ARTICLE; BABOON; CHANNEL GATING; DRUG EFFECT; HEART ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARRHYTHMIA; CATHETERIZATION; CROMAKALIM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PAPIO; PROPRANOLOL; TIME FACTORS;

EID: 0033979992     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200002000-00016     Document Type: Article

References (4)

1. D'Alonzo AJ, Grover GJ. Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart. Cardiovasc Res 1994;28:924-5.
2. de La Coussaye JE, Eledjam JJ, Bruelle P, et al. Electrophysiologic and arrhythmogenic effects of the potassium channel agonist BRL-38227 in anaesthetised dogs. J Cardiovasc Pharmacol 1993;22: 722-30.
3. Spinelli W, Follmer C, Parsons R, Colatsky T. Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs. Eur J Pharmacol 1990;179:243-52.
4. ATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovasc Res 1994;881-7.